Clinical Trial: S-Equol in Alzheimer's Disease 2 Trial

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: S-Equol in Alzheimer's Disease 2 (SEAD2) Trial

Brief Summary: By doing this study researchers hope to learn if S-equol, a compound that acts like estrogen in the body, causes an increase in mitochondrial activity. Researchers also hope to determine the safety and tolerability of a therapeutic dose of S-equol and whether or not it influences cognition.